Reply to Focosi et al
Clin Infect Dis
.
2023 Feb 8;76(3):554-555.
doi: 10.1093/cid/ciac744.
Authors
Hana Golding
1
,
Surender Khurana
1
Affiliation
1
Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, 20993, USA.
PMID:
36074895
DOI:
10.1093/cid/ciac744
No abstract available
Publication types
Letter
Comment